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Background and Aims: Few studies have described relations between exposure to laboratory animals and
the incidence of laboratory animal allergy (LAA). Studies that have found exposure-response relations
have been cross sectional in design or have focused on exposure to rats and mice. This study used
longitudinal data collected over a 12 year period to describe the relations between indices of exposure to
laboratory animals and the development of LAA and LAA symptoms.
Methods: Data were obtained from questionnaires and serological laboratory results from a dynamic
cohort of workers exposed to a variety of laboratory animals in a pharmaceutical manufacturing
company. Poisson regression was used to model the incidence rate ratios of species specific and general
LAA and LAA symptoms at different levels of exposure.
Results: The 12 year incidence rates of LAA symptoms and LAA for all workers were 2.26 (95% CI 1.61 to
2.91) and 1.32 (95% CI 0.76 to 1.87) per 100 person-years, respectively. Higher rate ratios were seen
with increasing reported hours of exposure to tasks that required working with animal cages or with many
animals at one time. The most common symptoms were related to rhinitis rather than to asthma.
Conclusions: This study suggests that the risk of LAA increases with duration of exposure to animals and
work in animal related tasks. Incidence might be reduced by limiting hours per week of exposure to
laboratory animals.
A
llergy is a common occupational hazard for workers
exposed to laboratory animals. Although prevalence
estimates vary depending on the definition of labora-
tory animal allergy (LAA), large studies have estimated that
10% to 23% of exposed workers report symptoms of allergy to
laboratory animals.1–3 These estimates do not include workers
who may have left the workplace after developing symptoms.
As the magnitude of the problem has becomemore apparent,
interest has turned to describing the exposure-response
relations between animal allergens and the development of
allergy. One study examining these relations found that certain
endpoints, such as chest and skin symptoms, are associated
with increasing intensity of exposure to rat urinary allergy
(RUA).4 5 Another study found a relation between increasing
cumulative exposure and sensitisation to RUA.6
Studies that have not directly addressed exposure-response
relations have reported LAA prevalence by job title.2 4 7–10 The
findings of these studies have been inconsistent, with higher
LAA prevalence in workers with intensive exposures (for
example, cage cleaners, animal handlers)4 7 8 as well as with
presumably low level, prolonged exposures (for example,
scientists, experimental assistants).2 9
Most studies have focused on exposure to RUA or to
rodents in general as these laboratory animals are used in
abundance and have allergenic proteins that are easily
identified and measured.4–6 11 However, a potentially impor-
tant aspect of exposure-response relations is the nature of the
allergens to which workers are exposed. It has been
suggested that workers may develop allergies more easily to
some animals than to others12 and that the potential for
sensitisation is related to the nature of the animal allergen.6
This study describes the relations between exposures to a
variety of laboratory animals and the development of LAA and
LAA symptoms in a dynamic cohort of workers over a 12 year
period. We examined relations between different indices of
exposure and the incidence of LAA, using annual self-reported
exposure information about job titles, hours worked with
specific animals, and hours spent at different tasks.
METHODS
The data for this study were obtained from medical records of
workers with potential exposure to laboratory animals at any
time during the period 1 January 1991 through 30 April 2003
at GlaxoSmithKline (GSK), a pharmaceutical company in
Research Triangle Park, North Carolina. All workers with
potential exposure were enrolled in an LAA surveillance
programme, which included annual medical examinations,
baseline and periodic serological tests for antibodies to
specific animals, and completion of a questionnaire obtaining
self-reported exposures and symptoms related to laboratory
animals. The programme and questionnaire have been
described in more detail in a previous study,12 and the
questionnaire has been made available elsewhere.13 The
surveillance programme was one component of an overall
laboratory allergy prevention programme, which also
included training, education, and implementation of engi-
neering controls.
Exposure indices
Estimates of exposure to laboratory animals in general were
derived from the following questions: ‘‘How many days per
week do you work with lab animals or their cages?’’ and
‘‘During these days, how many hours per day (on average) do
you work with lab animals or their cages?’’ Workers were
asked to give estimates for the past six months if they did not
work with animals on a weekly basis. Exposure to laboratory
animals in general was reported as a continuous variable, in
hours per week.
Exposures to specific laboratory animals were derived from
the question ‘‘How many hours per week do you usually have
contact with the following species?’’ Workers were asked
about six species in particular, with the option of reporting
additional species. Exposures to specific laboratory animals
were reported as ordinal variables, as they appeared on the
Abbreviations: GSK, GlaxoSmithKline; LAA, laboratory animal allergy;
RAST, radioallergosorbent test; RUA, rat urinary allergy
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questionnaire (0 hours per week, 1–6 hours per week,
7–20 hours per week, .20 hours per week). To assess the
influence of working with several species at different
frequency levels, an intensity score was calculated by
summing the midpoints of exposure categories across species.
Exposures to specific tasks were reported from a question
about hours per week involved in 13 specific work tasks, with
ordinal responses as previously described for exposure to
specific animals. Tasks have been used in other studies as a
surrogate for intensity of exposure.2 4 9 Job titles were
evaluated and categorised into major groups based on job
descriptions and similarities of tasks. When a job title was
not recognisable, senior staff of the GSK animal facility
checked the employee record to identify the employee’s job.
Health outcomes
Health outcomes for initial analyses included allergy to
laboratory animals in general and allergies to individual
animal species. General LAA (that is, not species specific)
was defined as having one or more self-reported work related
symptoms (runny or stuffy nose, watery or itchy eyes,
sneezing, coughing, wheezing or chest tightness, shortness
of breath, skin rashes) from exposure to laboratory animals,
with serological evidence of sensitisation to at least one
laboratory animal. Sensitisation was defined as any positive
radioallergosorbent test (RAST) to a panel of laboratory
animal allergens (rat urine, rat epithelium, mouse urine,
mouse epithelium, guinea pig urine, rabbit urine, cat dander,
dog dander). Species specific LAA was defined as having one
or more self-reported symptoms from exposure to a specific
species, with serological evidence of sensitisation to that
species. In assessment of species specific allergy, analyses
included only those species named on the questionnaire and
tested by RAST (rat, mouse, rabbit, guinea pig, and dog).
Additional analyses focused on the incidence of symptoms
alone, without consideration of serological data. Outcomes
included self-reported symptoms from exposure to laboratory
animals in general and to specific species.
Serological studies
Blood samples collected from workers at baseline and
subsequent examinations were sent to the same laboratory
over the 12 year period to be tested for antibodies to allergens
present in rat skin, rat urine, mouse skin, mouse urine,
guinea pig urine, cat dander, dog dander, and rabbit urine.
The test methods have been described elsewhere.14 15 The
materials and procedures were the same throughout the
period of testing. Different batches of the same antibody were
radiolabelled approximately every 3–4 months. New acti-
vated disks were prepared every 2–3 years and disks were
coupled to allergen every 1–2 years. The commercial allergens
(epithelia) had three year dating and were obtained from
Greer Laboratories (Lenoir, NC, USA). The animal urines
used in analysis were collected by veterinarians at the testing
laboratory and stored at 220 C̊.
The methods have been tested against the Pharmacia CAP
system, showing good correlation. In this study, a test was
considered positive with 0.8–1.9% specific binding, corre-
sponding to a Pharmacia CAP Class 2.
Data analysis
All workers who did not report symptoms to laboratory
animals at their initial examination and completed at least
one subsequent questionnaire were included in the analyses
495 with follow up included
in analyses
(2080 person-years)
603 completed at least two
questionnaires
108 had LAA on
first questionnaire
792 enrolled
Figure 1 Participation of employees enrolled in laboratory animal
allergy surveillance programme at GlaxoSmithKline Inc during
01/01/91 to 30/04/03.
Table 1 Distribution of workers, cases, and incidence












Workers in study 495 47 2.26 (1.61–2.91)
Workers without
prior exposure
140 (28.3) 20 4.26 (2.40–6.13)
Workers with prior
exposure
355 (71.2) 27 1.82 (1.14–2.51)
Males 291 (58.8) 24 1.88 (1.13–2.63)
Female 203 (41.0) 23 2.87 (1.69–4.04)
White 379 (76.6) 32 2.00 (1.31–2.69)
African-American 73 (14.8) 13 4.11 (1.88–6.35)
Other 42 ( 8.5) 2 1.23 (0–2.95)
Age (years)
18 to ,28 74 (14.9) 9 9.18 (3.18–15.18)
28 to ,38 224 (45.2) 20 2.86 (1.60–4.11)
38 to ,48 141 (28.4) 12 1.30 (0.56–2.04)
48 to ,68 50 (10.1) 6 1.72 (0.34–3.10)
Follow up (years)
1 to 3 271 (54.8) 32 7.29 (4.76–9.82)
4 to 6 102 (20.6) 11 2.35 (0.96–3.73)
7 to 9 52 (10.5) 1 0.23 (0–0.69)
9 to 13 70 (14.1) 3 0.40 (0–0.86)
Atopics1 158 (31.9) 28 4.54 (2.86–6.23)
Non-atopics 337 (68.1) 19 1.30 (0.72–1.89)
Workers with
serological data
305 (61.6) 37 1.32 (0.76–1.87)`
*Percentages that do not add to 100 reflect missing data.
Includes workers with who began employment before study inception, but
may have reported no prior exposure on their baseline questionnaire.
`Incidence of LAA (symptoms+positive RAST).
1MD diagnosed allergy.
Table 2 Incidence rate ratios of LAA symptoms (with
95% confidence intervals) for workers (including non-
atopic and atopic separately) with increasing hours per
week of exposure to laboratory animals or their cages,

















0 to 6 1.0 (referent) 1.0 (referent) 1.0 (referent)
.6 to 9 4.0 (1.6–10.3) – 6.7 (2.4–18.9)
.9 to 25 1.8 (0.9–3.6) 1.8 (0.6–5.2) 1.7 (0.7–4.4)
.25 2.7 (1.2–5.8) 3.2 (1.1–9.4) 2.5 (0.8–7.4)
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of LAA symptoms incidence. Of these, only workers with
serological data were included in analyses of LAA incidence.
Estimation of person-time
Person-time for fixed factors was calculated from the dates of
the first and last available questionnaires. Person-time for
changing factors, such as exposure to specific animals or
tasks, was calculated by summing person-years for each
exposure over periods based on dates of questionnaires.
When annual questionnaires were missing, simple imputa-
tions were made based on exposure distributions from non-
missing questionnaires. For example, if rat exposure was
reported in 61.2% of the non-missing person-time, the
imputed rat exposure for the missing person-time was
(61.2% 6 number of missing person-years). Total person-
time was calculated by summing the non-missing and
imputed estimates. To reflect the uncertainty in these
estimates, a range of imputations was estimated with the
assumption that exposure during the missing person-years
may have been as much as 50% greater or 50% less than in
the years with non-missing data.
Statistical methods
Incidence rates were calculated for the total population and
for different worker groups. Species specific rates were
estimated using person-years of exposure to each species,
and also using a standard denominator representing person-
years of exposure to laboratory animals in general. Poisson
regression was used to model the incidence rate ratios of
species specific and general LAA (and LAA symptoms) at
different levels of exposure.16 Exposures were evaluated in
univariate models and in multivariable models including
other factors that have been of interest in studies of LAA.
These included smoking, pet ownership, physician diagnosed
allergy, and family history of allergy or asthma, all self-
reported on the questionnaires. Physician diagnosed allergy
was used as a surrogate for atopy, and analyses were
stratified by atopic status. Age and sex were also evaluated.
Precision was reported as 95% confidence intervals. When
analysis results were similar for LAA and LAA symptoms,
only the latter was reported due to greater precision.
Statistical analyses were conducted using PC SAS software
version 8.2 (SAS Institute, Cary, NC, USA) and Stata v.8
(College Station, TX, USA).
RESULTS
Figure 1 illustrates the number of employees enrolled in
surveillance and included in analyses. Workers who did not
complete at least two questionnaires either left employment
before a follow up examination or began employment in the
last years of the study and had not yet reported for a follow
up examination.
Many workers intermittently failed to attend their annual
clinic visits, resulting in intervals of greater than one year
between questionnaires. Only 52% of the workers had
complete data for their entire follow up period. The mean
missing person-time was 1.15 years (SD 1.58), and the range
was 0–8 years. Mean missing person-time was higher for
non-cases (1.76 years (SD 1.66)) than for cases (1.04 years
(SD 1.27)).
Distribution of workers, cases, and LAA incidence rates for
time-invariant worker characteristics are shown in table 1.
Workers contributed 2080 person-years to the study, but
questionnaires covered only 1517 (73%) person-years. Over
the 12 year period, 47 workers developed symptoms to
laboratory animals, with an estimated incidence rate of
2.26 per 100 person-years. The highest incidence rates were
for workers 18–28 years of age and for workers with
1–3 years of follow up. Of the workers who developed LAA
symptoms, 87.8% developed symptoms of rhinitis, 18.3%
developed symptoms of asthma, and 20.5% developed skin
rash (data not shown).
When the study population was restricted to workers with
available serological data (n=305), the incidence rate of LAA
was 1.32 per 100 person-years. The incidence rate of LAA
symptoms among the reduced group was 2.22 cases per 100
person-years, similar to that of the total population. The
incidence rate was increased when analysis was restricted to
workers without prior exposure to laboratory animals (IR
4.26, 95% CI 2.40 to 6.13). Incidence rate ratios were higher
for workers with more than six hours per week exposure to
laboratory animals or their cages (table 2).
Species specific sensitisation (positive RAST) and LAA
(positive RAST in addition to self-reported symptoms) were
highest for mice and rats (fig 2). Sensitisation to rabbits and
dogs was similar, although more workers reported symptoms
to rabbits. None of the workers reporting symptoms to rabbits
had positive RAST to rabbit urinary allergen. Data are not
shown for hamsters, because no workers reported symptoms
to them, and serological studies did not include hamster
allergens. Species specific incidence rates, estimated using

















Mouse Rat Dog Rabbit Guinea pig
Symptoms among workers 
with serology (n = 305)
Species-specific LAA
Figure 2 Distribution of RAST results, species specific laboratory
animal allergy (LAA) symptoms, and LAA among workers with





















Rat Mouse Rabbit Guinea pig Dog
Figure 3 Estimated incidence rates
(with 95% confidence intervals) of
species specific allergy symptoms, using
imputed values for person-years of
exposure where questionnaires were
missing. The ranges for species specific
rates are derived from different
imputations of missing data.
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that rates are higher for allergy to rabbits than for other
animals (fig 3).
Sparse data prevented detailed evaluation of relations
between exposure to specific animals and the incidence of
species specific LAA and LAA symptoms. The estimated rate
ratios generally increased with hours/week exposure to most
animals, but the confidence intervals were wide (data not
shown). Further analyses for species specific allergy were
discontinued.
Rate ratios for LAA symptoms, comparing each job title
with the rate for the combined population, are shown in
table 3. Animal care workers had the highest rate (rate ratio
3.96, 95% CI 2.15 to 7.28), while scientists and lab
technicians had the lowest rates (rate ratios 0.58, 95% CI
0.27 to 1.21, and 0.43, 95% CI 0.06 to 3.08, respectively).
Rate ratios for tasks associated with work involving
exposure to cages or many animals increased with hours of
exposure (fig 4A). Rate ratios for tasks related to laboratory
work, such as dosing, weighing, and experimentation, and
jobs that did not require work with many animals at one
time, were lower and generally did not increase with








































































Figure 4 (A) Incidence rate ratios
(95% confidence intervals) from
univariate Poisson regression for
exposure to tasks associated with
working with cages or many animals:
a, handle dirty cages; b, return clean
cages; c, receive animals (no estimate
available for exposure at 7–20 hours/
week); d, change bedding; e, work in
holding room (referent = 0 hours/
week). (B) Incidence rate ratios (95%
confidence intervals) for exposure to
tasks associated with working with few
animals: f, gavage; g, weighing
animals; h, sacrifice/necropsy; i,
breeding room; j, housekeeping; k,
isolators; l, using animals outside
facility (no estimate available for
exposure at .20 hours/week); m,
isolated organ or tissue experiments
(estimate available only for exposure at
1–6 hours/week) (referent = 0 hours/
week).
Table 3 Incidence rate ratios for job titles, comparing rate for each job title with
population rate (2.26 cases per 100 person-years, 95% CI 1.61 to 2.90). As job titles are
reported each year of follow up and may change over period of employment, rates for job








(range) Rate ratios (95% CI)
Animal care specialist 12 75 9.0 32.1 (18–59) 3.96 (2.15–7.28)
Associate scientist 8 100 7.6 33.1 (18–56) 3.16 (1.53–6.52)
Assistant scientist 2 29 2.0 30.6 (22–48) 2.95 (0.75–11.58)
Supervisory 10 112 17.8 38.4 (25–61) 1.69 (0.86–3.30)
Support staff 1 26 2.0 36.6 (22–53) 1.47 0.21–10.33)
Animal health 2 17 4.4 34.5 (23–51) 1.36 (0.34–5.48)
Toxicology 3 45 8.0 36.2 (18–61) 1.12 (0.35–3.56)
Scientist 8 254 41.9 37.3 (24–62) 0.58 (0.27–1.21)
Lab technician 1 68 7.0 37.9 (18–63) 0.43 (0.06–3.08)
*Not mutually exclusive.
Age at entering job category.
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family history of allergy, age, and sex were evaluated in the
models, the estimates did not substantially change.
DISCUSSION
We estimated incidence rates of LAA and LAA symptoms for
different worker groups in a dynamic cohort of workers
exposed to laboratory animals in a pharmaceutical company.
The 12 year incidence rates of LAA and LAA symptoms for all
workers were 1.32 (95% CI 0.76 to 1.87) and 2.26 (95% CI
1.61 to 2.91) per 100 person-years. Incidence rates were
increased for workers aged 18–28 years and for workers with
follow up of 1–3 years. Incidence rate ratios were elevated for
workers with more than six hours per week exposure to
laboratory animals or their cages, although there did not
appear to be a dose-response relation.
Animal care specialists had the highest rates of LAA
symptoms, compared with the entire population. Rate ratios
increased with increasing hours per week of exposure to
tasks that involved working with cages or many animals at
the same time. Previous studies have shown higher concen-
trations of RUA associated with these tasks.17–19 We also
found lower rate ratios for tasks associated with handling a
few animals (for example, weighing, gavage or other dosing)
or using tissues for experimentation, tasks for which
measured RUA levels have been low in other studies.17–19
The results did not differ substantially when analyses were
stratified by atopic status, defined as physician diagnosed
allergy.
Analysis of species specific data suggested that rates of
allergy symptoms were higher for exposure to rabbits than to
other animals, perhaps a result of different types of exposure.
For example, rabbits shed more fur and frequently spray their
urine (personal communication, head of GSK animal facil-
ity). Workers reporting symptoms from exposure to rabbits
did not have serological evidence of sensitisation to rabbit
urine, but it is possible that they had symptoms to allergens
not included in the RAST assays. It is also possible that these
workers developed symptoms from exposure to other
unmeasured/unidentified allergens or irritants, such as
endotoxin, dust mites, and cleaning agents.
This is one of the first studies to describe relations between
levels of exposure to laboratory animals and development of
LAA and LAA symptoms. Other studies have been cross
sectional in design or of shorter duration, and have generally
focused on sensitisation to rat urinary aeroallergen.5 6 This
dynamic population of laboratory animal workers has been
followed systematically for a longer period than other
reported populations, which has allowed calculation of more
stable incidence rates for different worker groups.
The study was affected by missing person-time data arising
from missed clinic appointments, resulting in questionnaire
intervals of greater than one year for many workers. These
gaps in the data prevented direct calculation of incidence
rates for species specific allergy, as total person-time working
with each type of animal was not known for some workers.
Similarly, total person-years could be calculated for stable
characteristics that did not vary over time, but not for
characteristics that could change during the course of the
study. For example, missing data prevented the calculation of
cumulative exposure over the study period. We calculated
rates for job titles even though they could change over an
employment period, because it is likely that workers remain
in similar job tracts (for example, scientific work, animal care
work) throughout employment.
Some cases of LAA were reported after data gaps of two
years, although the mean interval between questionnaires for
all workers was approximately 1.1 years. If these workers
developed LAA during the period of missing person-time, it is
possible they self-selected to jobs with lower exposure, which
would result in increased rate ratios at lower levels of
exposure. Approximately 50% (n=5) of the cases with data
gaps reported lower exposures on the questionnaire in which
they reported allergy symptoms, but only three cases reported
decreases of greater than two hours per week.
If exposures were reported differentially by cases and non-
cases, with cases reporting higher exposures, the resultant
misclassification would yield rate ratios that exaggerated the
effects of exposure. However, examination of exposure
patterns for cases does not support the reporting of higher
exposures at the time of reporting allergies.
A potential problem with using this population in an
incidence study is that many of the workers had been
employed at GSK for a period of time before inception of the
study. Workers at high risk for LAA may have developed
symptoms and dropped out of the workforce before the study
began (healthy worker survivor effect). Under these condi-
tions, the rates of allergy from our study would likely be
underestimates of actual rates.
The comparison of observed incidence rates among jobs
may have been affected by health related selection. A
substantial proportion of the cohort (355 workers) had
worked with laboratory animals before entry into the study
and these workers had lower rates of incident LAA than
workers without previous exposure. This pattern might be a
result of job requirements and hiring practices: comparison of
job titles at entry into the cohort revealed that positions
requiring specialised training or experience—such as scien-
tists—tended to be filled by individuals who had worked
with laboratory animals before, whereas less skilled jobs—
such as those related to animal care—were more often held
by individuals who had not been exposed to animals
previously. Increased LAA incidence among workers with
no previous exposure could thus reflect assignment of
inexperienced workers to less skilled jobs with greater
exposures to allergens. However, it is also consistent with
the possibility that exposed workers who develop symptoms
early leave the industry, so that those who remain are a less
sensitive subgroup with lower risk of subsequent symptoms.
In this case, exposure related differences in LAA incidence
between jobs would be attenuated. Although it is not possible
to evaluate directly whether either of these processes is
relevant, neither is likely to create the appearance of an
exposure effect where none exists.
Many workers in this population came from previous jobs
with exposure to laboratory animals, so it is unlikely that
there was a truly unexposed group. People who work with
laboratory animals tend to be in highly specialised and
frequently mobile fields, such as science, veterinary medicine,
and toxicology, or they have received intense training in the
care of laboratory animals. If these workers change jobs, they
may be likely to seek jobs in similar fields.
Non-occupational exposure to animals, particularly house-
hold pets, may confound the occupational exposure to
animals because many animals used in the laboratory are
the same animals kept as pets. Hollander et al3 found allergies
to cats and dogs as an important risk factor for LAA. In this
population, 64% of the animal workers had pets. We were not
able to demonstrate an association between pet ownership
and LAA incidence, but we did find higher rate ratios for
workers with pet allergies.
This study suggests that a reduction in exposure to tasks
involving work with cages or many animals at one time may
result in decreased LAA incidence. Engineering and admin-
istrative controls have already been developed to mitigate
exposure to animal allergens, but it may be necessary to focus
continued efforts in this important area. Information from
this study may be useful in implementing administrative
controls that will regulate exposure for some workers. The
770 Elliott, Heederik, Marshall, et al
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information may also be useful in targeting specific areas for
measuring animal allergens in the occupational environment,
with the purpose of quantifying the exposure-response
relations.
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Policy implications
N LAA prevention strategies should include reduction of
hours per week of exposure to tasks related to working
with many animals or their cages.
N Environmental monitoring of animal facilities, with
focus on tasks and specific animals, may help to
elucidate exposure-response relations between animal
allergens and the development of allergy.
Main messages
N Incidence of laboratory animal allergy (LAA) increases
with increasing hours of week exposure to tasks
associated with working with many animals or their
cages.
N Rates of allergy symptoms may be related to the type of
animal to which a worker is exposed.
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